• Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

  • 2024/10/24
  • 再生時間: 21 分
  • ポッドキャスト

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

  • サマリー

  • Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
    続きを読む 一部表示

あらすじ・解説

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

  • Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinomaに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。